Xilio Therapeutics (XLO) Stock Chart & Stock Price History $0.90 +0.02 (+2.07%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Xilio Therapeutics Stock Price Performance The Xilio Therapeutics (XLO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 28.14%, with a year-to-date return of -5.95%. In the past month, the stock has increased 19.51%, reflecting recent market activity. As of the latest close, Xilio Therapeutics traded at $0.88 with a market cap of $45.57 million and volume of 396,539 shares. Receive XLO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+12.28%1 Month Performance+19.51%3 Month Performance-15.26%Year-To-Date Performance-5.95%1 Year Performance-28.14% XLO Stock Chart for Tuesday, May, 20, 2025 XLO Chart by TradingView Xilio Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/19/2025$0.86$0.88+2.40%$0.92$0.82396,539 shs$45.57 million05/16/2025$0.80$0.86+7.43%$0.90$0.78828,119 shs$44.50 million05/15/2025$0.85$0.80-5.88%$0.86$0.78998,246 shs$41.42 million05/14/2025$1.15$0.85-26.09%$1.07$0.843.77 million shs$44.01 million05/13/2025$0.73$1.15+57.32%$1.18$0.8834.28 million shs$59.54 million05/12/2025$0.71$0.73+2.96%$0.75$0.704.42 million shs$37.85 million05/09/2025$0.72$0.71-1.39%$0.75$0.70143,699 shs$36.76 million05/08/2025$0.67$0.72+8.03%$0.74$0.66175,220 shs$37.28 million05/07/2025$0.69$0.67-3.85%$0.70$0.66422,905 shs$34.51 million05/06/2025$0.74$0.69-6.30%$0.73$0.69290,851 shs$35.89 million Get the Latest News and Ratings for XLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/05/2025$0.75$0.74-1.39%$0.76$0.72123,741 shs$38.30 million05/02/2025$0.76$0.75-0.64%$0.78$0.7558,658 shs$38.84 million05/01/2025$0.77$0.76-1.40%$0.78$0.74114,124 shs$39.09 million04/30/2025$0.76$0.77+1.30%$0.77$0.71178,566 shs$39.64 million04/29/2025$0.79$0.76-3.73%$0.80$0.73124,723 shs$39.14 million04/28/2025$0.83$0.79-5.23%$0.84$0.76155,728 shs$40.65 million04/25/2025$0.84$0.83-1.13%$0.84$0.80125,027 shs$42.90 million04/24/2025$0.79$0.84+5.55%$0.85$0.79180,462 shs$43.39 million04/23/2025$0.81$0.79-1.99%$0.82$0.7998,505 shs$41.10 million04/22/2025$0.82$0.81-0.61%$0.86$0.80247,623 shs$41.94 million04/21/2025$0.75$0.82+8.44%$0.82$0.74298,549 shs$42.20 million Related Companies PBYI Stock Chart KRRO Stock Chart LFVN Stock Chart SLS Stock Chart FTLF Stock Chart NKTX Stock Chart CYBN Stock Chart TNGX Stock Chart NLTX Stock Chart EPRX Stock Chart Receive XLO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:XLO) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersAI Firm Enters America's Largest Medicaid MarketNew York's $95B system just approved a new AI healthcare platform. Here's what to know. A major shift in U....i2i Marketing Group, LLC | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | Sponsored“Buy” Alert! This stock could soar by July 31stTHREE companies in particular are leading the charge during this exciting time. Here’s why I’m so excited a...Traders Agency | SponsoredTrump’s treachery A shocking bill has been put before the House of Representatives… Representative Brandon Gill wants Preside...Porter & Company | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xilio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
